<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3587042/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Familial Defective Apolipoprotein B-100 and Increased Low-Density Lipoprotein Cholesterol and Coronary Artery Calcification in the Old Order Amish</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587042/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Archives of internal medicine"><meta name="citation_title" content="Familial Defective Apolipoprotein B-100 and Increased Low-Density Lipoprotein Cholesterol and Coronary Artery Calcification in the Old Order Amish"><meta name="citation_authors" content="Haiqing Shen, Coleen M. Damcott, Evadnie Rampersaud, Toni I. Pollin, Richard B. Horenstein, Patrick F. McArdle, Patricia A. Peyser, Lawrence F. Bielak, Wendy S. Post, Yen-Pei C. Chang, Kathleen A. Ryan, Michael Miller, John A. Rumberger, Patrick F. Sheedy, II, John Shelton, Jeffrey R. O’Connell, Alan R. Shuldiner, Braxton D. Mitchell"><meta name="citation_date" content="8 November 2010"><meta name="citation_issue" content="20"><meta name="citation_volume" content="170"><meta name="citation_firstpage" content="1850"><meta name="citation_doi" content="10.1001/archinternmed.2010.384"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3587042/?report=abstract"><meta name="citation_pmid" content="21059979"><meta name="DC.Title" content="Familial Defective Apolipoprotein B-100 and Increased Low-Density Lipoprotein Cholesterol and Coronary Artery Calcification in the Old Order Amish"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Haiqing Shen"><meta name="DC.Contributor" content="Coleen M. Damcott"><meta name="DC.Contributor" content="Evadnie Rampersaud"><meta name="DC.Contributor" content="Toni I. Pollin"><meta name="DC.Contributor" content="Richard B. Horenstein"><meta name="DC.Contributor" content="Patrick F. McArdle"><meta name="DC.Contributor" content="Patricia A. Peyser"><meta name="DC.Contributor" content="Lawrence F. Bielak"><meta name="DC.Contributor" content="Wendy S. Post"><meta name="DC.Contributor" content="Yen-Pei C. Chang"><meta name="DC.Contributor" content="Kathleen A. Ryan"><meta name="DC.Contributor" content="Michael Miller"><meta name="DC.Contributor" content="John A. Rumberger"><meta name="DC.Contributor" content="Patrick F. Sheedy, II"><meta name="DC.Contributor" content="John Shelton"><meta name="DC.Contributor" content="Jeffrey R. O’Connell"><meta name="DC.Contributor" content="Alan R. Shuldiner"><meta name="DC.Contributor" content="Braxton D. Mitchell"><meta name="DC.Date" content="2010 Nov 8"><meta name="DC.Identifier" content="10.1001/archinternmed.2010.384"><meta name="DC.Language" content="en"><meta property="og:title" content="Familial Defective Apolipoprotein B-100 and Increased Low-Density Lipoprotein Cholesterol and Coronary Artery Calcification in the Old Order Amish"><meta property="og:type" content="article"><meta property="og:description" content="Elevated low-density lipoprotein cholesterol (LDL-C) levels are a major cardiovascular disease risk factor. Genetic factors are an important determinant of LDL-C levels.To identify single nucleotide polymorphisms associated with LDL-C and subclinical ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587042/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3587042/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3587042/pdf/nihms447098.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8B44C3DD511E910000000008A60597.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3587042%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3587042</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Arch Intern Med</a></span>. Author manuscript; available in PMC 2013 Mar 4.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=21059979" target="pmc_ext" ref="reftype=publisher&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Arch Intern Med. 2010 Nov 8; 170(20): 1850–1855. </span></a></div> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1001%2Farchinternmed.2010.384" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1001/archinternmed.2010.384</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3587042</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS447098</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/21059979">21059979</a></div></div></div></div><h1 class="content-title">Familial Defective Apolipoprotein B-100 and Increased Low-Density Lipoprotein Cholesterol and Coronary Artery Calcification in the Old Order Amish</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Shen%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Haiqing Shen</a>, MD, PhD, <a href="/pubmed/?term=Damcott%20CM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Coleen M. Damcott</a>, PhD, <a href="/pubmed/?term=Rampersaud%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Evadnie Rampersaud</a>, MSPH, PhD, <a href="/pubmed/?term=Pollin%20TI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Toni I. Pollin</a>, MS, PhD, <a href="/pubmed/?term=Horenstein%20RB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Richard B. Horenstein</a>, MD, <a href="/pubmed/?term=McArdle%20PF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Patrick F. McArdle</a>, PhD, <a href="/pubmed/?term=Peyser%20PA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Patricia A. Peyser</a>, PhD, <a href="/pubmed/?term=Bielak%20LF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Lawrence F. Bielak</a>, DDS, MPH, <a href="/pubmed/?term=Post%20WS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Wendy S. Post</a>, MD, MS, <a href="/pubmed/?term=Chang%20YP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Yen-Pei C. Chang</a>, PhD, <a href="/pubmed/?term=Ryan%20KA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Kathleen A. Ryan</a>, MPH, <a href="/pubmed/?term=Miller%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Michael Miller</a>, MD, <a href="/pubmed/?term=Rumberger%20JA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">John A. Rumberger</a>, PhD, MD, <a href="/pubmed/?term=Sheedy%20PF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Patrick F. Sheedy, II</a>, MD, <a href="/pubmed/?term=Shelton%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">John Shelton</a>, BS, <a href="/pubmed/?term=O%26%23x02019%3BConnell%20JR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Jeffrey R. O’Connell</a>, PhD, <a href="/pubmed/?term=Shuldiner%20AR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Alan R. Shuldiner</a>, MD, and  <a href="/pubmed/?term=Mitchell%20BD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21059979">Braxton D. Mitchell</a>, PhD</div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140438158191008_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140438158191008_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140438158191008_ai" style="display:none"><div class="fm-affl" id="A1" lang="en">Divisions of Endocrinology, Diabetes, and Nutrition (Drs Shen, Damcott, Rampersaud, Pollin, Horenstein, McArdle, Chang, O’Connell, Shuldiner, and Mitchell, and Ms Ryan and Mr Shelton) and Cardiology (Dr Miller), University of Maryland School of Medicine, Baltimore; Geriatric Research and Education Clinical Center, Veterans Administration Medical Center (Dr Shuldiner), Baltimore, Maryland; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor (Drs Peyser and Bielak); Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore (Dr Post); Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore (Dr Post); The Princeton Longevity Center, Princeton, New Jersey (Dr Rumberger); and Department of Diagnostic Radiology, Mayo Clinic and Foundation, Rochester, Minnesota (Dr Sheedy). Dr Rampersaud is now with the Department of Human Genetics, University of Miami Miller School of Medicine, Miami, Florida</div><div id="cor1"><strong>Correspondence:</strong> Braxton D. Mitchell, PhD, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, 660 W Redwood St, Room 492, Baltimore, MD 21201 (<a href="mailto:dev@null" data-email="ude.dnalyramu.enicidem@lehctimb" class="oemail">ude.dnalyramu.enicidem@lehctimb</a>)</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140438158191008_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=21059979" target="pmc_ext" ref="reftype=publisher&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Arch Intern Med</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3587042/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="idm140438095173504" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140438095173504title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Background</h3><p id="P1" class="p p-first-last">Elevated low-density lipoprotein cholesterol (LDL-C) levels are a major cardiovascular disease risk factor. Genetic factors are an important determinant of LDL-C levels.</p></div><div id="S2" class="sec"><h3 id="S2title">Methods</h3><p id="P2" class="p p-first-last">To identify single nucleotide polymorphisms associated with LDL-C and subclinical coronary atherosclerosis, we performed a genome-wide association study of LDL-C in 841 asymptomatic Amish individuals aged 20 to 80 years, with replication in a second sample of 663 Amish individuals. We also performed scanning for coronary artery calcification (CAC) in 1018 of these individuals.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">From the initial genome-wide association study, a cluster of single nucleotide polymorphisms in the region of the apolipoprotein B-100 gene (<em>APOB</em>) was strongly associated with LDL-C levels (<em>P</em> &lt; 10<sup>−68</sup>). Additional genotyping revealed the presence of <em>R3500Q</em>, the mutation responsible for familial defective apolipoprotein B-100, which was also strongly associated with LDL-C in the replication sample (<em>P</em> &lt; 10<sup>−36</sup>). The <em>R3500Q</em> carrier frequency, previously reported to be 0.1% to 0.4% in white European individuals, was 12% in the combined sample of 1504 Amish participants, consistent with a founder effect. The mutation was also strongly associated with CAC in both samples (<em>P</em> &lt; 10<sup>−6</sup> in both) and accounted for 26% and 7% of the variation in LDL-C levels and CAC, respectively. Compared with noncarriers, <em>R3500Q</em> carriers on average had LDL-C levels 58 mg/dL higher, a 4.41-fold higher odds (95% confidence interval, 2.69–7.21) of having detectable CAC, and a 9.28-fold higher odds (2.93–29.35) of having extensive CAC (CAC score ≥400).</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusion</h3><p id="P4" class="p p-first-last">The <em>R3500Q</em> mutation in <em>APOB</em> is a major determinant of LDL-C levels and CAC in the Amish.</p></div></div></div><div id="idm140438118601152" class="tsec sec headless whole_rhythm"><p id="P5" class="p p-first">Elevated low-density lipoprotein cholesterol (LDL-C) levels are associated with an increased risk of cardiovascular disease (CVD). Twin and family studies<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540722">1</a>–<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540718">3</a></sup> suggest that 40% to 80% of the population variation in levels of LDL-C is attributable to genetic factors. The variability in LDL-C levels in the general population is likely polygenic and affected by environmental factors. Rare forms of monogenic hypercholesterolemia have been identified, including familial hypercholesterolemia due to mutations in the LDL receptor gene and familial defective apolipoprotein B-100 due to mutations in the apolipoprotein B (OMIM 107730) (<em>APOB</em>).<sup><a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540698">4</a>,<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540696">5</a></sup></p><p id="P6" class="p">To identify genes associated with variations in LDL-C levels and their relation with sub clinical coronary atherosclerosis, we performed a genome-wide association study (GWAS) on LDL-C levels in a socially and culturally homogeneous Old Order Amish population residing in Lancaster County, Pennsylvania. Almost all the participants descended from fewer than 300 founders who emigrated from Switzerland during the 1700s. Their diet is relatively homogeneous, and their use of cholesterol-lowering medications is low, minimizing the effect of environmental factors that might obscure or modify genetic determinants of LDL-C levels.</p></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">METHODS</h2><div id="S6" class="sec sec-first"><h3 id="S6title">STUDY POPULATION</h3><p id="P7" class="p p-first">This study began with a GWAS of LDL-C levels in an initial cohort of 841 individuals (stage 1). Stage 1 individuals were participants in the Heredity and Phenotype Intervention (HAPI) Heart Study,<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540700">6</a></sup> which was initiated in 2003 to identify genes that interact with short-term environmental exposures to modify risk factors for CVD. Participants were members of the Old Order Amish community aged 20 years or older and considered to be relatively healthy based on the exclusion criteria of severe hypertension (blood pressure &gt; 180/105 mm Hg), malignancy, and kidney, liver, or untreated thyroid disease. Further description of the HAPI Heart Study design is available on request from the authors.</p><p id="P8">The HAPI Heart Study participants underwent measurement of CVD risk factors and questioning about their history of CVD. Physical examinations were conducted at the Amish Research Clinic in Strasburg, Pennsylvania. Blood samples were collected after an overnight fast. Those taking lipid-lowering medications at enrollment (7 participants) discontinued use 7 days before examination. Serum lipid and high-density lipoprotein cholesterol levels were assayed by Quest Diagnostics (Horsham, Pennsylvania).All the participants had triglyceride levels lower than 400 mg/dL (to convert to millimoles per liter, multiply by 0.0113), and LDL-C levels were calculated according to the formula of Friedewald et al.<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540694">7</a></sup> Lipoprotein sub fractions were measured using Vertical Auto Profile technology (VAP; Atherotech, Birmingham, Alabama). Hypertension was defined as a systolic blood pressure of 140 mm Hg or higher, a diastolic blood pressure of 90 mm Hg or higher, or use of prescription blood pressure–lowering medications. Diabetes mellitus was defined as a fasting glucose level of 126 mg/dL or higher (to convert to millimoles per liter, multiply by 0.0555) or current use of prescription medications for diabetes. Smoking habits were recorded; current smoking status included the use of cigarettes, pipes, or cigars. The measurements for coronary artery calcification (CAC) by electron beam computed tomography were available in 355 HAPI Heart Study participants.</p><p id="P9" class="p p-last">In stage 2, we genotyped an independent sample of 663 Old Order Amish individuals aged 30 years or older in whom we had measured serum lipid levels and CAC. These individuals had previously been recruited into the Amish Family Calcification Study between 2002 and 2006 to identify the genetic determinants of CAC.<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_433502759">8</a></sup> Participants were recruited without regard to their CVD status. The study protocol was approved by the institutional review board at the University of Maryland and participating institutions. Informed consent was obtained from each of the study participants.</p></div><div id="S7" class="sec"><h3 id="S7title">GENOTYPING</h3><p id="P10" class="p p-first">Genotyping was performed in all stage 1 study participants using the Affymetrix GeneChip Human Mapping 500K Array Set (Affymetrix, Santa Clara, California), including 500 568 single-nucleotide polymorphisms (SNPs). The Affymetrix GeneChip Genotyping Analysis Software and BRLMM genotype-calling algorithm were used to generate SNP data files. The mean genotype call rate in the stage 1 sample was 98.3%. The SNPs (n = 98 806) with minor allele frequencies less than 2% in the overall sample were removed from further analyses. Finally, 369 241 SNPs that passed quality control and Hardy-Weinberg equilibrium checks (at <em>P</em> &lt; .001) were retained for analysis.</p><p id="P11" class="p p-last">A region on chromosome arm 2p showed strong evidence of association, implicating the nearby gene, <em>APOB</em>, as an attractive positional candidate gene. To determine whether the observed association could be explained by the presence of the <em>APOB R3500Q</em> (OMIM 107730.0009) (rs5742904) mutation, which is responsible for familial defective <em>APOB-100</em>, we genotyped this variant in stage 1 and 2 participants using Custom TaqMan SNP Genotyping Assays (Applied Biosystems, Foster City, California).</p></div><div id="S8" class="sec"><h3 id="S8title">CAC SCORING</h3><p id="P12" class="p p-first-last">Coronary artery calcification was measured by electron beam computed tomography using an Imatron C-150 scanner (Imatron Inc, San Francisco, California) (scanning protocol available on request from the authors). Coronary artery calcification was quantified using the Agatston method, which incorporates density and area.<sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540721">9</a></sup> The sum of the Agatston scores in the 4 epicardial arteries was considered the CAC score.</p></div><div id="S9" class="sec sec-last"><h3 id="S9title">STATISTICAL ANALYSIS</h3><p id="P13" class="p p-first">Association analyses of LDL-C levels and other quantitative traits were performed under a variance component model that assesses the effect of genotype, as an additive effect, on the quantitative trait while simultaneously estimating the effects of age, age<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540713">2</a></sup>, sex, and a polygenic component to account for phenotypic correlation due to relatedness. The polygenic component was modeled using the relationship matrix derived from the complete pedigree structure because all the participants are related. Association analysis using the complete pedigree structure was performed using mixed-model analysis for pedigree software developed by one of us (J.R.O.).We considered a genome-wide significance threshold to be <em>P</em> &lt; 10<sup>−7</sup>.</p><p id="P14">Pairwise linkage disequilibrium correlation statistics (<em>r</em><sup>2</sup>) were computed using Haploview software (<a href="http://www.broadinstitute.org/haploview/haploview" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.broadinstitute.org/haploview/haploview</a>). Power calculations using the Genetic Power Calculator program<sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540708">10</a></sup> indicated we would have 80% power to detect SNPs in the stage 1 sample (n = 841) accounting for approximately 4% of phenotypic variation at α = 10<sup>−7</sup>. For example, a SNP accounting for 4% of the trait variance in LDL-C levels that had an allele frequency of 0.20 would be associated with a 13- to 14-mg/dL (to convert to millimoles per liter, multiply by 0.0259) increase in LDL-C per copy of the mutant allele.</p><p id="P15" class="p p-last">Because the distribution of CAC scores was positively skewed, the scores were natural log-transformed after adding 1.<sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540715">11</a></sup> Age- and sex-adjusted CAC scores were calculated using linear regression, and standardized residuals were obtained. The residuals, which were approximately normally distributed, were used for analysis of CAC quantity. Odds ratios describing the association between the <em>R3500Q</em> mutation and the presence of CAC and having extensive CAC (CAC score ≥400) were estimated using generalized estimating equations incorporated into SAS version 9.1 (SAS Institute, Inc, Cary, North Carolina), with sibship membership included as a random effect. All reported <em>P</em> values are 2-sided and are not adjusted for multiple comparisons.</p></div></div><div id="S10" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S10title">RESULTS</h2><p id="P16" class="p p-first">The clinical characteristics of stage 1 and 2 participants are given in <a href="/pmc/articles/PMC3587042/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>. The mean ages of the stage 1 and 2 samples were 43.7 and 59.6 years, respectively. The mean (SE) heritability of LDL-C, adjusted for age, age<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540710">2</a></sup>, and sex, was 0.60 (0.07) (<em>P</em> = 1.2 × 10<sup>−20</sup>) in the stage 1 samples and 0.51 (0.08) (<em>P</em> = 2.8 × 10<sup>−14</sup>) in the stage 2 samples.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="P37">Clinical Characteristics of the Stage 1 and 2 Participants</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140438093177888" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="bottom" align="left">Characteristic</th><th rowspan="1" colspan="1" align="left">Stage 1<br>(n=841)</th><th rowspan="1" colspan="1" align="left">Stage 2<br>(n=663)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">Age, mean (SD), y</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;43.7 (13.9)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;59.6 (13.1)</td></tr><tr><td rowspan="1" colspan="1" align="left">Male, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;453 (53.9)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;290 (43.7)</td></tr><tr><td rowspan="1" colspan="1" align="left">BMI, mean (SD)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;26.5 (4.5)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;28.3 (5.4)</td></tr><tr><td rowspan="1" colspan="1" align="left">Blood pressure, mean (SD), mm Hg</td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;Systolic</td><td rowspan="1" colspan="1" align="left">121.1 (14.7)</td><td rowspan="1" colspan="1" align="left">119.9 (17.5)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;Diastolic</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;76.5 (8.7)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;70.8 (9.0)</td></tr><tr><td rowspan="1" colspan="1" align="left">Cholesterol, mean (SD), mg/dL</td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;Total</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;208 (46)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;214 (43)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;LDL-C</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;139 (43)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;139 (40)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;HDL-C</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56 (14)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56 (15)</td></tr><tr><td rowspan="1" colspan="1" align="left">Triglycerides, median (IQR), mg/dL</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56 (42–80)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;78 (56–114)</td></tr><tr><td rowspan="1" colspan="1" align="left">Hypertension, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;115 (13.7)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;154 (23.2)</td></tr><tr><td rowspan="1" colspan="1" align="left">Diabetes mellitus, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5 (0.6)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27 (4.1)</td></tr><tr><td rowspan="1" colspan="1" align="left">Current smoker, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90 (10.7)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49 (7.4)</td></tr><tr><td rowspan="1" colspan="1" align="left">Lipid medication use, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7 (0.8)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45 (6.8)</td></tr><tr><td rowspan="1" colspan="1" align="left">Self-reported history of CVD, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22 (2.6)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;81 (12.2)</td></tr><tr><td rowspan="1" colspan="1" align="left">Presence of CAC, score ≥1, No. (%)<sup>a</sup></td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;137 (38.6)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;394 (59.4)</td></tr><tr><td rowspan="1" colspan="1" align="left">Extensive CAC, score ≥400, No. (%)<sup>a</sup></td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24 (6.8)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;122 (18.4)</td></tr><tr><td rowspan="1" colspan="1" align="left">CAC score, median (IQR)<sup>a</sup></td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 (0–24.6)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;11.3 (0–233.1)</td></tr></tbody></table></div><div id="largeobj_idm140438093177888" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3587042/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="P38" class="p p-first-last">Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CAC, coronary artery calcification; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol.</p></div><div id="TFN2"><p id="P39" class="p p-first-last">SI conversion factors: To convert HDL-C, LDL-C, and total cholesterol to millimoles per liter, multiply by 0.0259; triglycerides to millimoles per liter, multiply by 0.0113.</p></div><div id="TFN3"><sup>a</sup>Available for 355 participants in stage 1 and 663 participants in stage 2.</div></div></div><p id="P17">In the GWAS, the strongest SNP associations with LDL-C levels were observed for a cluster of 68 SNPs spanning a 12-megabases region on chromosome arm 2p, with <em>P</em> values ranging from <em>P</em> &lt; 10<sup>−9</sup> to a peak association of <em>P</em> &lt; 10<sup>−68</sup> for the SNP rs4971516 (300 kilobases [kb] downstream of the <em>APOB</em> gene) (additive model, minor allele frequency = 0.056). (Detailed GWAS results of LDL-C levels are available on request from the authors.)</p><p id="P18">One gene in the associated region, <em>APOB</em>, located 300 kb downstream of rs4971516, was considered the most compelling positional candidate gene for several reasons. First, the phenotypic distribution of LDL-C and the strength of the observed associations indicated the presence of a highly penetrant allele. Second, rare mutations in <em>APOB</em> have been found in patients with familial defective<em>APOB-100</em>.<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540720">5</a></sup> Third, examination of haplotypes among presumed carriers suggested the presence of an extended region of haplotype sharing that included <em>APOB</em> compatible with a single mutation transmitted through the population from a common ancestor. Thus, we hypothesized that a mutation in the <em>APOB</em> gene may have entered the Amish population and increased in frequency through genetic drift. We then genotyped <em>R3500Q</em> (dbSNP designation: rs5742904) in the stage 1 sample.</p><p id="P19"><em>R3500Q</em> was in near-complete linkage disequilibrium with rs4971516 (D’ = 0.99 and <em>r</em><sup>2</sup> = 0.96) and was strongly associated with total cholesterol (<em>P</em> = 1.60 × 10<sup>−40</sup>) and LDL-C (<em>P</em> = 1.84 × 10<sup>−52</sup>) levels and with the presence (<em>P</em> &lt; .001) and quantity (<em>P</em> = 6.67 × 10<sup>−7</sup>) of CAC comparing <em>R3500Q</em> heterozygote carriers with noncarriers (<a href="/pmc/articles/PMC3587042/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). The frequency of the <em>R3500Q</em> allele was 0.064; the 12% of the population that carried the mutant allele had LDL-C levels approximately 61 mg/dL higher than those of noncarriers. We performed an additional GWAS that included <em>APOB R3500Q</em> in the model as a covariate but did not identify any further SNPs significantly associated with LDL-C concentrations (data not shown).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="P41">Characteristics of the Study Sample According to <em>APOB R3500Q</em> Genotype in Stages 1 and 2<sup>a</sup></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140438124360912" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left"></th><th colspan="8" rowspan="1" align="center"><em>R3500Q</em> Genotype</th></tr><tr><th rowspan="1" colspan="1" align="left"></th><th colspan="8" rowspan="1" valign="bottom" align="center"><hr></th></tr><tr><th rowspan="1" colspan="1" align="left"></th><th colspan="4" rowspan="1" align="center">Stage 1</th><th colspan="4" rowspan="1" align="center">Stage 2</th></tr><tr><th rowspan="1" colspan="1" align="left"></th><th colspan="4" rowspan="1" valign="bottom" align="center"><hr></th><th colspan="4" rowspan="1" valign="bottom" align="center"><hr></th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="left">Characteristic</th><th rowspan="1" colspan="1" align="left"><em>RR</em><br>(n=731)</th><th rowspan="1" colspan="1" align="left"><em>RQ</em><br>(n=106)</th><th rowspan="1" colspan="1" align="left"><em>QQ</em><br>(n=2)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em> Value<sup>b</sup></th><th rowspan="1" colspan="1" align="left"><em>RR</em><br>(n=585)</th><th rowspan="1" colspan="1" align="left"><em>RQ</em><br>(n=75)</th><th rowspan="1" colspan="1" align="left"><em>QQ</em><br>(n=3)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em> Value<sup>b</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">Age, mean (SD), y</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;43.9 (13.9)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;41.8 (14.5)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;59.0 (5.7)</td><td rowspan="1" colspan="1" align="center">.16</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;59.8 (12.9)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;57.3 (14.0)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;70.0 (17.8)</td><td rowspan="1" colspan="1" align="center">.12</td></tr><tr><td rowspan="1" colspan="1" align="left">Male, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;395 (54.0)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58 (54.7)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</td><td rowspan="1" colspan="1" align="center">.90</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;260 (44.4)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29 (38.7)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 (33.3)</td><td rowspan="1" colspan="1" align="center">.34</td></tr><tr><td rowspan="1" colspan="1" align="left">BMI, mean (SD)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;26.6 (4.5)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;26.0 (4.6)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;21.6 (2.7)</td><td rowspan="1" colspan="1" align="center">.21</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;28.3 (5.6)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;28.6 (4.5)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;27.4 (3.7)</td><td rowspan="1" colspan="1" align="center">.90</td></tr><tr><td rowspan="1" colspan="1" align="left">Blood pressure, mean (SD), mm Hg</td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Systolic</td><td rowspan="1" colspan="1" align="left">121.1 (14.9)</td><td rowspan="1" colspan="1" align="left">120.7 (13.5)</td><td rowspan="1" colspan="1" align="left">143.0 (19.8)</td><td rowspan="1" colspan="1" align="center">.65</td><td rowspan="1" colspan="1" align="left">119.7 (17.8)</td><td rowspan="1" colspan="1" align="left">121.1 (15.7)</td><td rowspan="1" colspan="1" align="left">124.3 (23.2)</td><td rowspan="1" colspan="1" align="center">.48</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diastolic</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;76.6 (8.6)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;75.3 (9.4)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;76.0 (2.8)</td><td rowspan="1" colspan="1" align="center">.31</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;70.8 (9.1)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;70.6 (8.9)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;68.0 (2.6)</td><td rowspan="1" colspan="1" align="center">.41</td></tr><tr><td rowspan="1" colspan="1" align="left">Cholesterol, mean (SD), mg/dL</td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;Total</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;200 (40)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;260 (49)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;391 (18)</td><td rowspan="1" colspan="1" align="center">1.60×10<sup>−40</sup></td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;208 (37)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;259 (55)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;296 (83)</td><td rowspan="1" colspan="1" align="center">1.48×10<sup>−23</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;LDL-C</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;130 (35)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;193 (43)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;327 (5)</td><td rowspan="1" colspan="1" align="center">1.84×10<sup>−52</sup></td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;133 (32)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;187 (52)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;221 (88)</td><td rowspan="1" colspan="1" align="center">2.37×10<sup>−37</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;HDL-C</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56 (15)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;54 (14)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56 (15)</td><td rowspan="1" colspan="1" align="center">.37</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;57 (15)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52 (16)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;55 (13)</td><td rowspan="1" colspan="1" align="center">.06</td></tr><tr><td rowspan="1" colspan="1" align="left">Triglycerides, median (IQR), mg/dL</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59 (43–88)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;51 (40–73)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;43 (37–48)</td><td rowspan="1" colspan="1" align="center">.07</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;77 (56–114)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;88 (54–121)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;74 (68–145)</td><td rowspan="1" colspan="1" align="center">.37</td></tr><tr><td rowspan="1" colspan="1" align="left">Hypertension, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;105 (14.4)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9 (8.5)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 (50.0)</td><td rowspan="1" colspan="1" align="center">.10</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;134 (22.9)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19 (25.3)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 (33.3)</td><td rowspan="1" colspan="1" align="center">.64</td></tr><tr><td rowspan="1" colspan="1" align="left">Diabetes mellitus, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5 (0.7)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</td><td rowspan="1" colspan="1" align="center">.39</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23 (3.9)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4 (5.3)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</td><td rowspan="1" colspan="1" align="center">.56</td></tr><tr><td rowspan="1" colspan="1" align="left">Current smoker, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;79 (10.8)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11 (10.4)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</td><td rowspan="1" colspan="1" align="center">.89</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44 (7.5)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5 (6.7)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</td><td rowspan="1" colspan="1" align="center">.79</td></tr><tr><td rowspan="1" colspan="1" align="left">Lipid medication use, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4 (0.6)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3 (2.8)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</td><td rowspan="1" colspan="1" align="center">.02</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32 (5.5)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12 (16.0)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 (33.3)</td><td rowspan="1" colspan="1" align="center">&lt;.001</td></tr><tr><td rowspan="1" colspan="1" align="left">Self-reported history of CVD, No. (%)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18 (2.5)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3 (2.8)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 (50.0)</td><td rowspan="1" colspan="1" align="center">.82</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;72 (12.3)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8 (10.7)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 (33.3)</td><td rowspan="1" colspan="1" align="center">.48</td></tr><tr><td rowspan="1" colspan="1" align="left">Presence of CAC, score ≥1, No. (%)<sup>c</sup></td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;114 (35.2)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21 (72.4)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2 (100)</td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;340 (58.1)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52 (69.3)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2 (66.7)</td><td rowspan="1" colspan="1" align="center">&lt;.001</td></tr><tr><td rowspan="1" colspan="1" align="left">Extensive CAC, score ≥400, No. (%)<sup>c</sup></td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16 (4.9)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7 (24.1)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 (50.0)</td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;98 (16.8)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22 (29.3)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2 (66.7)</td><td rowspan="1" colspan="1" align="center">&lt;.001</td></tr><tr><td rowspan="1" colspan="1" align="left">CAC score, median (IQR)<sup>c</sup></td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 (0–8.9)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;72.2 (0–315.5)</td><td rowspan="1" colspan="1" align="left">763.1 (106.0–1420.1)</td><td rowspan="1" colspan="1" align="left">6.67×10<sup>−7</sup></td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;8.2 (0–203.2)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;99.2 (0–587.4)</td><td rowspan="1" colspan="1" align="left">585.0 (0–1997.9)</td><td rowspan="1" colspan="1" align="left">9.23×10<sup>−7</sup></td></tr></tbody></table></div><div id="largeobj_idm140438124360912" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3587042/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN4"><p id="P42" class="p p-first-last">Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CAC, coronary artery calcification; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol.</p></div><div id="TFN5"><p id="P43" class="p p-first-last">SI conversion factors: To convert HDL-C, LDL-C, and total cholesterol to millimoles per liter, multiply by 0.0259; triglycerides to millimoles per liter, multiply by 0.0113.</p></div><div id="TFN6"><sup>a</sup>The size of the subsamples does not total 1504 because 2 participants in stage 1 failed the follow-up <em>R3500Q</em> genotype.</div><div id="TFN7"><sup>b</sup>Based on comparison of <em>RR</em> genotype with <em>RQ</em> genotype groups because of the small number in the <em>QQ</em> genotype group. All the comparisons were adjusted for age, age<sup>2</sup>, sex, and family structure. Lipid levels were further adjusted for the use of lipid-lowering medications. The <em>P</em> values for triglycerides are based on natural logarithm transformation. Percentage comparisons are based on the χ<sup>2</sup> test.</div><div id="TFN8"><sup>c</sup>The CAC comparisons are based on 324, 29, and 2 patients with the <em>RR</em>, <em>RQ</em>, and <em>QQ</em> genotypes, respectively, in stage 1 and on 585, 75, and 3 patients with the <em>RR</em>, <em>RQ</em>, and <em>QQ</em> genotypes, respectively, in stage 2. Patients with the <em>QQ</em> genotype were excluded as in the previous footnote because of the small sample size in this group. The <em>P</em> values for presence of (extensive) CAC were adjusted for age and sex. The <em>P</em> values for CAC score based on age- and sex-adjusted residuals were adjusted for use of lipid-lowering medication and family structure.</div></div></div><p id="P20">In stage 2 participants, the frequency of the <em>R3500Q</em> allele was 0.06. <em>R3500Q</em> was strongly associated with LDL-C levels (<em>P</em> &lt; 10<sup>−30</sup>) and accounted for an approximately 55-mg/dL increase in LDL-C levels. The mutation was associated with a higher prevalence (<em>P</em> &lt; .001) and quantity (<em>P</em> = 9.2 × 10<sup>−7</sup>) of CAC in this independent replication sample. <em>R3500Q</em> genotypes were not associated with LDL-C subclass particle patterns (data not shown) or appreciably with high-density lipoprotein cholesterol levels (<a href="/pmc/articles/PMC3587042/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>).</p><p id="P21">Because of the consistency of effect (61- and 55-mg/dL increases in LDL-C levels per allele in stages 1 and 2, respectively), stage 1 and 2 samples were combined to permit estimation of age- and sex-specific effects of the <em>R3500Q</em> mutation on LDL-C levels. <em>R3500Q</em> carriers had higher LDL-C levels in each age group and in both sexes (<a href="/pmc/articles/PMC3587042/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). In the combined sample, the <em>R3500Q</em> mutation accounted for 26% of the variation in age- and sex-adjusted LDL-C levels.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3587042/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140438111244176" class="figure"><a href="/pmc/articles/PMC3587042/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3587042_nihms447098f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms447098f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3587042/bin/nihms447098f1.jpg"></a></div><div id="largeobj_idm140438111244176" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3587042/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3587042/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="P35">Mean low-density lipoprotein cholesterol (LDL-C) levels in <em>APOB R3500Q</em> noncarriers and carriers in the combined sample by age in men (A) and women (B). To convert LDL-C to millimoles per liter, multiply by 0.0259. Error bars represent standard deviation.</p></div></div></div><p id="P22">The <em>R3500Q</em> mutation also accounted for 7% of the variation in adjusted CAC quantity in the combined sample. The prevalence of any detectable CAC and of extensive CAC (defined as a CAC score ≥400)<sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540704">11</a></sup> by age in the combined sample is shown in <a href="/pmc/articles/PMC3587042/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a> according to carrier status. Before age 40 years, the prevalence of CAC was low in carriers and noncarriers. After age 50 years, <em>R3500Q</em> carriers had greater prevalence of both any CAC and extensive CAC in every group. The <em>R3500Q</em> mutation accounted for 4.5% of CAC presence and 12.8% of extensive CAC presence in this population. After adjusting for age, sex, lipid lowering medication use, and sibship, <em>R3500Q</em> carriers had a 4.41-fold higher odds (95% confidence interval [CI], 2.69–7.21) of having detectable CAC compared with non carriers. Moreover, carriers had an increased risk of having a CAC score of at least 400 compared with noncarriers (odds ratio [OR], 9.28; 95% CI, 2.93–29.35) (<a href="/pmc/articles/PMC3587042/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3587042/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140438120432544" class="figure"><a href="/pmc/articles/PMC3587042/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3587042_nihms447098f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms447098f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3587042/bin/nihms447098f2.jpg"></a></div><div id="largeobj_idm140438120432544" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3587042/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3587042/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="P36">Prevalence of detectable and extensive coronary artery calcification (CAC) in <em>APOB R3500Q</em> noncarriers (RR) and carriers (RQ) in the combined sample by age group.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="P47">ORs for the Presence of CAC and Extensive CAC Among <em>APOB R3500Q</em> Carriers Compared With Noncarriers in the Combined Sample<sup>a</sup></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140438124008944" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left"></th><th colspan="2" rowspan="1" valign="bottom" align="left">Model 1</th><th colspan="2" rowspan="1" align="left">Model 2:<br>Model 1 + LDL-C</th></tr><tr><th rowspan="1" colspan="1" align="left"></th><th colspan="2" rowspan="1" valign="bottom" align="left"><hr></th><th colspan="2" rowspan="1" valign="bottom" align="left"><hr></th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="left">Variable</th><th rowspan="1" colspan="1" valign="bottom" align="left">OR (95% CI)</th><th rowspan="1" colspan="1" align="center"><em>P</em><br>Value</th><th rowspan="1" colspan="1" valign="bottom" align="left">OR (95% CI)</th><th rowspan="1" colspan="1" align="left"><em>P</em><br>Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">Presence of CAC<sup>b</sup></td><td rowspan="1" colspan="1" align="left">4.41 (2.69–7.21)</td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1" align="left">3.18 (1.81–5.59)</td><td rowspan="1" colspan="1" align="left">&lt;.001</td></tr><tr><td rowspan="1" colspan="1" align="left">Presence of extensive CAC<sup>c</sup></td><td rowspan="1" colspan="1" align="left">9.28 (2.93–29.35)</td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1" align="left">5.43 (1.54–19.18)</td><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;.009</td></tr></tbody></table></div><div id="largeobj_idm140438124008944" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3587042/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN9"><p id="P48" class="p p-first-last">Abbreviations: CAC, coronary artery calcium; CI, confidence interval; LDL-C, low-density lipoprotein cholesterol; OR, odds ratio.</p></div><div id="TFN10"><sup>a</sup>The model 1 covariates were age, sex, use of lipid-lowering medication, and sibships. Additional adjustment for body mass index, systolic and diastolic blood pressure, high-density lipoprotein cholesterol, and smoking did not appreciably change the results.</div><div id="TFN11"><sup>b</sup>A CAC score ≥1 vs &lt;1.</div><div id="TFN12"><sup>c</sup>A CAC score ≥400 vs &lt;1.</div></div></div><p id="P23">To determine whether the increase in CAC in <em>APOB R3500Q</em> carriers could be explained by increased LDL-C levels measured at a single time point, we assessed the effects of <em>R3500Q</em> on the degree of CAC after additional adjustment for LDL-C levels in the combined sample. After this adjustment, the <em>R3500Q</em> mutation explained 4.1% of the residual variance in the degree of CAC. Even with LDL-C in the model, <em>R3500Q</em> remained a strong independent predictor of CAC presence (OR, 3.18; 95% CI, 1.81–5.59) and of extensive CAC (5.43; 1.54–19.18) (<a href="/pmc/articles/PMC3587042/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>).</p><p id="P24" class="p p-last">Results of the association analyses were confirmed using the family-based association test (FBAT).<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540699">12</a></sup> These analyses revealed excess <em>R3500Q</em> transmission to be associated with higher LDL-C levels (<em>P</em> = 4.0 × 10<sup>−11</sup>) and a greater degree of CAC (<em>P</em> = 10<sup>−5</sup>).</p></div><div id="S11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S11title">COMMENT</h2><p id="P25" class="p p-first">The surprising finding from this study was the identification of the <em>R3500Q</em> mutation in <em>APOB</em> as a major determinant of LDL-C levels and CAC in the Old Order Amish. This mutation accounted for approximately 13% of extensive CAC in the population, a substantial effect given that CAC is strongly associated with the risk of future cardiovascular events. The present sample included 181 carriers of the <em>R3500Q</em> allele (ie, approximately 1 of every 8–9 participants), a much higher frequency for this mutation than in any other single population previously reported.<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540706">13</a></sup> Because the Old Order Amish in Lancaster County are descendents of approximately 300 founders who emigrated to Pennsylvania from Switzerland in the latter part of the 1700s,<sup><a href="#R14" rid="R14" class=" bibr popnode">14</a></sup> we speculate that the <em>R3500Q</em> mutation was introduced into the population by a single founding ancestor and has been maintained in the population at relatively high frequency through genetic drift.</p><p id="P26">The <em>R3500Q</em> mutation, which is responsible for familial defective apolipoprotein B-100,<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540703">5</a></sup> is believed to prevent the proper folding of apolipoprotein B by altering the interactions between 2 amino acids, thereby reducing the ability of the LDL-C particle to bind to the LDL receptor.<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540701">15</a></sup> The precise effects of this mutation on CVD risk have been hard to quantify because previous studies have either included few participants sampled from the general population or have focused on samples enriched with prevalent ischemic heart disease. In the largest published population sample, the <em>APOB R3500Q</em> mutation was associated with total cholesterol levels 100 mg/dL higher and LDL-C levels 82 mg/dL higher based on only 7 carriers identified through a population screen of 9255 Danes<sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540709">16</a></sup> compared with the present estimated effect sizes of 55 mg/dL for total cholesterol and 58 mg/dL for LDL-C based on a sample of 181 carriers. Previous studies<sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540712">16</a>–<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540697">18</a></sup> based on identification of individuals with hypercholesterolemia or ischemic heart disease have reported even larger effect sizes. <em>R3500Q</em> has been associated with ischemic heart disease, although a clear effect of this mutation on early coronary artery atherosclerosis has not been established. These findings reinforce the idea that the <em>APOB R3500Q</em> mutation may increase ischemic heart disease risk by increasing LDL-C levels and CAC. This view is supported by evidence that the <em>APOB R3500Q</em> mutation is a direct cause of elevated LDL-C levels, the known associations of <em>APOB R3500Q</em> and LDL-C levels with ischemic heart disease, and previous studies,<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_433502760">8</a>,<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540717">19</a>–<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540716">21</a></sup> including from this population,<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_433502758">8</a></sup> showing that LDL-C concentrations are associated with the degree and presence of CAC.</p><p id="P27">The association between the <em>R3500Q</em> mutation and CAC could not be accounted for entirely by a 1-time measure of LDL-C levels because the <em>R3500Q</em> mutation remained strongly associated with CAC even after adjusting for or stratifying by LDL-C. A possible explanation is that <em>R3500Q</em> carriers have been exposed to a lifelong increase in LDL-C levels, which cannot be captured by a single cross-sectional LDL-C measurement. Alternatively, the mutation may be associated with features related to LDL-C metabolism that affect CAC development independently of circulating LDL-C levels. However, through this analysis of LDL sub particle distributions, we found no evidence to suggest that the mutation was associated with more atherogenic LDL.</p><p id="P28">Controlling for <em>R3500Q</em> in the GWAS abolished almost all other associations with SNPs in the chromosome 2 region (data not shown). However, many SNPs in this region are in high-linkage disequilibrium, and carriers of the <em>R3500Q</em> mutation share a common extended haplotype. We, thus, cannot exclude the possibility that there might be other variants in linkage disequilibrium with <em>R3500Q</em> that are functional and contribute to elevated LDL-C levels and increased CAC levels. However, given what is known about the <em>R3500Q</em> mutation,<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540719">15</a>,<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540711">22</a></sup> there does not seem to be a strong rationale for positing the presence of additional functional variants in the region that co-segregate with the <em>R3500Q</em> mutation. Even if such variants did exist, it would be difficult to detect and attribute functional consequences to them because of the limited recombination along the at-risk haplotype.</p><p id="P29">The <em>R3500Q</em> mutation is relatively uncommon in non-Amish populations. Population-based surveys have reported carrier frequencies of 1 per 500 to 1 per 1250,<sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540714">23</a></sup> and a carrier frequency of 1 per 209 has been reported in a Swiss population.<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540707">13</a></sup> Of 1840 individuals genotyped in the Baltimore-Washington Stroke Prevention in Young Women Study,<sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540705">24</a></sup> we identified 2 heterozygotes, for a carrier rate of 0.11% (range, 0.02%–0.44%), in line with prior estimates of 0.08% to 0.41% reported from population-based studies.<sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_300540693">23</a></sup> Importantly, even this low rate corresponds to a large number of carriers at the population level. For example, a carrier rate of 0.1% in the United States (2008 estimated population size of 305 million<sup><a href="#R25" rid="R25" class=" bibr popnode">25</a></sup>) would translate into an estimated 305 000 <em>R3500Q</em> carriers. The markedly increased level of LDL-C and degree of CAC due to this single mutation have potentially important implications for personalized medicine in the full US population and in the Amish population, in whom this mutation is enriched. Because <em>R3500Q</em> carriers are more likely than noncarriers to have an increased burden of sub clinical coronary atherosclerosis even at the same LDL-C levels, such individuals may benefit from earlier and more aggressive treatment with lipid-lowering medications. Is there value in screening for <em>R3500Q</em> carriers at the population level? If so, how would this be most effectively accomplished, for example, by screening for the mutation or by screening for LDL-C levels? Prospective clinical trials are necessary to address these questions and to determine the most efficacious treatment strategies for carriers of this mutation, including at what age to start treatment.</p><p id="P30" class="p p-last">In summary, we demonstrated that carriers of the <em>R3500Q</em> mutation in <em>APOB</em> are frequent in the Old Order Amish. In this population, the <em>R3500Q</em> mutation is a major determinant of LDL-C levels and CAC.</p></div><div id="S12" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S12title">Acknowledgments</h2><div class="sec"><p id="P33"><strong>Funding/Support:</strong> This work was supported by research grants R01 HL69313, R01 088119, R01 AR046838, U01 HL72515, and U01 <a id="__tag_810790671" class="tag_hotlink" href="/nuccore/HL084756" ref="/nuccore/HL084756"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"HL084756","term_id":"1051655164","term_text":"HL084756"}}</span>HL084756</a> from the National Institutes of Health and Scientist Development grant 0830146N (Dr Shen) and grant-in-aid 0855400E (Dr Mitchell) from the American Heart Association; grant M01 RR 16500 from the University of Maryland General Clinical Research Center; grant P30 DK072488 from the Mid-Atlantic Nutrition and Obesity Research Center; a grant from the General Clinical Research Centers Program, National Center for Research Resources, National Institutes of Health; and the Baltimore Veterans Administration Geriatric Research and Education Clinical Center. Dr Post was supported by the Paul Beeson Physician Faculty Scholars in Aging Program.</p><p id="P34"><strong>Additional Contributions:</strong> We acknowledge our Amish liaisons and field workers and the cooperation and support of the Amish community, without which these studies would have been impossible.</p></div></div><div id="idm140438124567328" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140438124567328title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><div><p id="P31" class="p p-first-last"><strong>Author Contributions:</strong>
<em>Study concept and design:</em> Post, Rumberger, Shuldiner, and Mitchell. <em>Acquisition of data:</em> Shen, Damcott, Horenstein, Post, Shelton, Shuldiner, and Mitchell. <em>Analysis and interpretation of data:</em> Shen, Damcott, Rampersaud, Pollin, McArdle, Peyser, Bielak, Post, Chang, Ryan, Miller, Rumberger, Sheedy, O’Connell, Shuldiner, and Mitchell. <em>Drafting of the manuscript:</em> Shen, Damcott, Miller, Sheedy, O’Connell, Shuldiner, and Mitchell. <em>Critical revision of the manuscript for important intellectual content:</em> Shen, Damcott, Rampersaud, Pollin, Horenstein, McArdle, Peyser, Bielak, Post, Chang, Ryan, Miller, Rumberger, Shelton, O’Connell, Shuldiner, and Mitchell. <em>Statistical analysis:</em> Shen, Pollin, McArdle, Ryan, Sheedy, O’Connell, and Mitchell. <em>Obtained funding:</em> Shen, Post, Shuldiner, and Mitchell. <em>Administrative, technical, and material support:</em> Damcott, Rumberger, Shelton, and Mitchell. <em>Study supervision:</em> Peyser and Mitchell.</p></div><p class="fn sec" id="FN2"></p><p id="P32" class="p p-first-last"><strong>Financial Disclosure:</strong> None reported.</p><p></p></div></div><div id="idm140438120381008" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140438120381008title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Beekman M, Heijmans BT, Martin NG, et al.  Heritabilities of apolipoprotein and lipid levels in three countries. <span><span class="ref-journal">Twin Res. </span>2002;<span class="ref-vol">5</span>(2):87–97.</span> [<a href="/pubmed/11931686" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Twin+Res&amp;title=Heritabilities+of+apolipoprotein+and+lipid+levels+in+three+countries&amp;author=M+Beekman&amp;author=BT+Heijmans&amp;author=NG+Martin&amp;volume=5&amp;issue=2&amp;publication_year=2002&amp;pages=87-97&amp;pmid=11931686&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Fenger M, Benyamin B, Schousboe K, Sørensen TI, Kyvik KO. Variance decomposition of apolipoproteins and lipids in Danish twins. <span><span class="ref-journal">Atherosclerosis. </span>2007;<span class="ref-vol">191</span>(1):40–47.</span> [published correction appears in <em>Atherosclerosis</em>. 2008;200(2):451]. [<a href="/pubmed/16730014" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Variance+decomposition+of+apolipoproteins+and+lipids+in+Danish+twins&amp;author=M+Fenger&amp;author=B+Benyamin&amp;author=K+Schousboe&amp;author=TI+Sørensen&amp;author=KO+Kyvik&amp;volume=191&amp;issue=1&amp;publication_year=2007&amp;pages=40-47&amp;pmid=16730014&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Mitchell BD, Kammerer CM, Blangero J, et al.  Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. <span><span class="ref-journal">Circulation. </span>1996;<span class="ref-vol">94</span>(9):2159–2170.</span> [<a href="/pubmed/8901667" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Genetic+and+environmental+contributions+to+cardiovascular+risk+factors+in+Mexican+Americans.+The+San+Antonio+Family+Heart+Study&amp;author=BD+Mitchell&amp;author=CM+Kammerer&amp;author=J+Blangero&amp;volume=94&amp;issue=9&amp;publication_year=1996&amp;pages=2159-2170&amp;pmid=8901667&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. <span><span class="ref-journal">Science. </span>1986;<span class="ref-vol">232</span>(4746):34–47.</span> [<a href="/pubmed/3513311" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=A+receptor-mediated+pathway+for+cholesterol+homeostasis&amp;author=MS+Brown&amp;author=JL+Goldstein&amp;volume=232&amp;issue=4746&amp;publication_year=1986&amp;pages=34-47&amp;pmid=3513311&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Soria LF, Ludwig EH, Clarke HR, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1989;<span class="ref-vol">86</span>(2):587–591.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC286517/">PMC free article</a>]</span> [<a href="/pubmed/2563166" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Association+between+a+specific+apolipoprotein+B+mutation+and+familial+defective+apolipoprotein+B-100&amp;author=LF+Soria&amp;author=EH+Ludwig&amp;author=HR+Clarke&amp;author=GL+Vega&amp;author=SM+Grundy&amp;volume=86&amp;issue=2&amp;publication_year=1989&amp;pages=587-591&amp;pmid=2563166&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Mitchell BD, McArdle PF, Shen H, et al.  The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study. <span><span class="ref-journal">Am Heart J. </span>2008;<span class="ref-vol">155</span>(5):823–828.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2443415/">PMC free article</a>]</span> [<a href="/pubmed/18440328" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+Heart+J&amp;title=The+genetic+response+to+short-term+interventions+affecting+cardiovascular+function:+rationale+and+design+of+the+Heredity+and+Phenotype+Intervention+(HAPI)+Heart+Study&amp;author=BD+Mitchell&amp;author=PF+McArdle&amp;author=H+Shen&amp;volume=155&amp;issue=5&amp;publication_year=2008&amp;pages=823-828&amp;pmid=18440328&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. <span><span class="ref-journal">Clin Chem. </span>1972;<span class="ref-vol">18</span>(6):499–502.</span> [<a href="/pubmed/4337382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=Estimation+of+the+concentration+of+low-density+lipoprotein+cholesterol+in+plasma,+without+use+of+the+preparative+ultracentrifuge&amp;author=WT+Friedewald&amp;author=RI+Levy&amp;author=DS+Fredrickson&amp;volume=18&amp;issue=6&amp;publication_year=1972&amp;pages=499-502&amp;pmid=4337382&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Post W, Bielak LF, Ryan KA, et al.  Determinants of coronary artery and aortic calcification in the Old Order Amish. <span><span class="ref-journal">Circulation. </span>2007;<span class="ref-vol">115</span>(6):717–724.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4039563/">PMC free article</a>]</span> [<a href="/pubmed/17261661" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Determinants+of+coronary+artery+and+aortic+calcification+in+the+Old+Order+Amish&amp;author=W+Post&amp;author=LF+Bielak&amp;author=KA+Ryan&amp;volume=115&amp;issue=6&amp;publication_year=2007&amp;pages=717-724&amp;pmid=17261661&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. <span><span class="ref-journal">J Am Coll Cardiol. </span>1990;<span class="ref-vol">15</span>(4):827–832.</span> [<a href="/pubmed/2407762" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Cardiol&amp;title=Quantification+of+coronary+artery+calcium+using+ultrafast+computed+tomography&amp;author=AS+Agatston&amp;author=WR+Janowitz&amp;author=FJ+Hildner&amp;author=NR+Zusmer&amp;author=M+Viamonte&amp;volume=15&amp;issue=4&amp;publication_year=1990&amp;pages=827-832&amp;pmid=2407762&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. <span><span class="ref-journal">Bioinformatics. </span>2003;<span class="ref-vol">19</span>(1):149–150.</span> [<a href="/pubmed/12499305" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Genetic+Power+Calculator:+design+of+linkage+and+association+genetic+mapping+studies+of+complex+traits&amp;author=S+Purcell&amp;author=SS+Cherny&amp;author=PC+Sham&amp;volume=19&amp;issue=1&amp;publication_year=2003&amp;pages=149-150&amp;pmid=12499305&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. <span><span class="ref-journal">J Am Coll Cardiol. </span>2005;<span class="ref-vol">46</span>(1):158–165.</span> [<a href="/pubmed/15992651" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Cardiol&amp;title=Coronary+calcification,+coronary+disease+risk+factors,+C-reactive+protein,+and+atherosclerotic+cardiovascular+disease+events:+the+St.+Francis+Heart+Study&amp;author=Y+Arad&amp;author=KJ+Goodman&amp;author=M+Roth&amp;author=D+Newstein&amp;author=AD+Guerci&amp;volume=46&amp;issue=1&amp;publication_year=2005&amp;pages=158-165&amp;pmid=15992651&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. <span><span class="ref-journal">Genet Epidemiol. </span>2000;<span class="ref-vol">19</span>(suppl 1):S36–S42.</span> [<a href="/pubmed/11055368" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genet+Epidemiol&amp;title=Implementing+a+unified+approach+to+family-based+tests+of+association&amp;author=NM+Laird&amp;author=S+Horvath&amp;author=X+Xu&amp;volume=19&amp;issue=suppl+1&amp;publication_year=2000&amp;pages=S36-S42&amp;pmid=11055368&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Miserez AR, Laager R, Chiodetti N, Keller U. High prevalence of familial defective apolipoprotein B-100 in Switzerland. <span><span class="ref-journal">J Lipid Res. </span>1994;<span class="ref-vol">35</span>(4):574–583.</span> [<a href="/pubmed/8006512" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Lipid+Res&amp;title=High+prevalence+of+familial+defective+apolipoprotein+B-100+in+Switzerland&amp;author=AR+Miserez&amp;author=R+Laager&amp;author=N+Chiodetti&amp;author=U+Keller&amp;volume=35&amp;issue=4&amp;publication_year=1994&amp;pages=574-583&amp;pmid=8006512&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Beiler K.  <span class="ref-journal">Church Directory of the Lancaster County Amish.</span> Gordonville, PA: Pequea Publishers; 2002.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Church+Directory+of+the+Lancaster+County+Amish&amp;author=K+Beiler&amp;publication_year=2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Boren J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity TL. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. <span><span class="ref-journal">J Clin Invest. </span>1998;<span class="ref-vol">101</span>(5):1084–1093.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC508660/">PMC free article</a>]</span> [<a href="/pubmed/9486979" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Identification+of+the+low+density+lipoprotein+receptor-binding+site+in+apolipoprotein+B100+and+the+modulation+of+its+binding+activity+by+the+carboxyl+terminus+in+familial+defective+apo-B100&amp;author=J+Boren&amp;author=I+Lee&amp;author=W+Zhu&amp;author=K+Arnold&amp;author=S+Taylor&amp;volume=101&amp;issue=5&amp;publication_year=1998&amp;pages=1084-1093&amp;pmid=9486979&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Tybjaerg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. <span><span class="ref-journal">N Engl J Med. </span>1998;<span class="ref-vol">338</span>(22):1577–1584.</span> [<a href="/pubmed/9603795" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Association+of+mutations+in+the+apolipoprotein+B+gene+with+hypercholesterolemia+and+the+risk+of+ischemic+heart+disease&amp;author=A+Tybjaerg-Hansen&amp;author=R+Steffensen&amp;author=H+Meinertz&amp;author=P+Schnohr&amp;author=BG+Nordestgaard&amp;volume=338&amp;issue=22&amp;publication_year=1998&amp;pages=1577-1584&amp;pmid=9603795&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Ludwig EH, Hopkins PN, Allen A, et al.  Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. <span><span class="ref-journal">J Lipid Res. </span>1997;<span class="ref-vol">38</span>(7):1361–1373.</span> [<a href="/pubmed/9254062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Lipid+Res&amp;title=Association+of+genetic+variations+in+apolipoprotein+B+with+hypercholesterolemia,+coronary+artery+disease,+and+receptor+binding+of+low+density+lipoproteins&amp;author=EH+Ludwig&amp;author=PN+Hopkins&amp;author=A+Allen&amp;volume=38&amp;issue=7&amp;publication_year=1997&amp;pages=1361-1373&amp;pmid=9254062&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Hansen PS, Defesche JC, Kastelein JJ, et al.  Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>1997;<span class="ref-vol">17</span>(4):741–747.</span> [<a href="/pubmed/9108789" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arterioscler+Thromb+Vasc+Biol&amp;title=Phenotypic+variation+in+patients+heterozygous+for+familial+defective+apolipoprotein+B+(FDB)+in+three+European+countries&amp;author=PS+Hansen&amp;author=JC+Defesche&amp;author=JJ+Kastelein&amp;volume=17&amp;issue=4&amp;publication_year=1997&amp;pages=741-747&amp;pmid=9108789&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. <span><span class="ref-journal">Atherosclerosis. </span>2009;<span class="ref-vol">202</span>(1):289–295.</span> [<a href="/pubmed/18452924" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Non-HDL+cholesterol+is+strongly+associated+with+coronary+artery+calcification+in+asymptomatic+individuals&amp;author=SH+Orakzai&amp;author=K+Nasir&amp;author=M+Blaha&amp;author=RS+Blumenthal&amp;author=P+Raggi&amp;volume=202&amp;issue=1&amp;publication_year=2009&amp;pages=289-295&amp;pmid=18452924&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Loria CM, Liu K, Lewis CE, et al.  Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. <span><span class="ref-journal">J Am Coll Cardiol. </span>2007;<span class="ref-vol">49</span>(20):2013–2020.</span> [<a href="/pubmed/17512357" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Cardiol&amp;title=Early+adult+risk+factor+levels+and+subsequent+coronary+artery+calcification:+the+CARDIA+Study&amp;author=CM+Loria&amp;author=K+Liu&amp;author=CE+Lewis&amp;volume=49&amp;issue=20&amp;publication_year=2007&amp;pages=2013-2020&amp;pmid=17512357&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">McCullough PA. Effect of lipid modification on progression of coronary calcification. <span><span class="ref-journal">J Am Soc Nephrol. </span>2005;<span class="ref-vol">16</span>(suppl 2):S115–S119.</span> [<a href="/pubmed/16251246" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Nephrol&amp;title=Effect+of+lipid+modification+on+progression+of+coronary+calcification&amp;author=PA+McCullough&amp;volume=16&amp;issue=suppl+2&amp;publication_year=2005&amp;pages=S115-S119&amp;pmid=16251246&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Borén J, Ekström U, Agren B, Nilsson-Ehle P, Innerarity TL. The molecular mechanism for the genetic disorder familial defective apolipoprotein B100. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>(12):9214–9218.</span> [<a href="/pubmed/11115503" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+molecular+mechanism+for+the+genetic+disorder+familial+defective+apolipoprotein+B100&amp;author=J+Borén&amp;author=U+Ekström&amp;author=B+Agren&amp;author=P+Nilsson-Ehle&amp;author=TL+Innerarity&amp;volume=276&amp;issue=12&amp;publication_year=2001&amp;pages=9214-9218&amp;pmid=11115503&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. <span><span class="ref-journal">Am J Epidemiol. </span>2004;<span class="ref-vol">160</span>(5):407–420.</span> [<a href="/pubmed/15321837" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol&amp;title=Genetic+causes+of+monogenic+heterozygous+familial+hypercholesterolemia:+a+HuGE+prevalence+review&amp;author=MA+Austin&amp;author=CM+Hutter&amp;author=RL+Zimmern&amp;author=SE+Humphries&amp;volume=160&amp;issue=5&amp;publication_year=2004&amp;pages=407-420&amp;pmid=15321837&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Song Q, Cole JW, O’Connell JR, et al.  Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. <span><span class="ref-journal">Hum Mol Genet. </span>2006;<span class="ref-vol">15</span>(16):2468–2478.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1634802/">PMC free article</a>]</span> [<a href="/pubmed/16835261" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=Phosphodiesterase+4D+polymorphisms+and+the+risk+of+cerebral+infarction+in+a+biracial+population:+the+Stroke+Prevention+in+Young+Women+Study&amp;author=Q+Song&amp;author=JW+Cole&amp;author=JR+O’Connell&amp;volume=15&amp;issue=16&amp;publication_year=2006&amp;pages=2468-2478&amp;pmid=16835261&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">US Census Bureau. National and state population estimates. Population Estimates Program, US Census Bureau.  [Accessed September 20, 2009];<span></span>  <a href="http://www.census.gov/popest/national/files/NST-EST2008-alldata.txt" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3587042&amp;issue-id=220226&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.census.gov/popest/national/files/NST-EST2008-alldata.txt</a>. Released December 22, 2008.</span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm140438095173504title">Abstract</a></li><li><a href="#S5title">METHODS</a></li><li><a href="#S10title">RESULTS</a></li><li><a href="#S11title">COMMENT</a></li><li><a href="#S12title">Acknowledgments</a></li><li><a href="#idm140438124567328title">Footnotes</a></li><li><a href="#idm140438120381008title">REFERENCES</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3587042/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3587042/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3587042/pdf/nihms447098.pdf">PDF (913K)</a></li> | <li><a href="#" data-citationid="PMC3587042" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3587042%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3587042%2F&amp;text=Familial%20Defective%20Apolipoprotein%20B-100%20and%20Increased%20Low-Density%20Lipoprotein%20Cholesterol%20and%20Coronary%20Artery%20Calcification%20in%20the%20Old%20Order%20Amish" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3587042%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="21059979" data-aiid="3587042" data-aid="3587042" data-iid="220226" data-domainid="319" data-domain="nihpa" data-accid="PMC3587042" data-md5="ca42ae8b062eb7157e99999717578b83"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T06:12:43-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal104&amp;ncbi_phid=CE8B44C3DD511E910000000008A60597&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3587042%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3587042/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>